ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 18 Issue : 1 Year: 2017
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Should physicians instead of industry representatives be the main actor of cardiac implantable electronic device follow-up? (Super Follow-up) [Anatol J Cardiol]
Anatol J Cardiol. 2017; 18(1): 23-30 | DOI: 10.14744/AnatolJCardiol.2017.7374  

Should physicians instead of industry representatives be the main actor of cardiac implantable electronic device follow-up? (Super Follow-up)

Çağın Mustafa Üreyen, Cem Yunus Baş, İsa Öner Yüksel, Görkem Kuş, Göksel Çağırcı, Şakir Arslan
Department of Cardiology, Antalya Education and Research Hospital; Antalya-Turkey

Objective: This retrospective study sought to research the adequacy of the follow-up and optimization of cardiac implantable electronic devices (CIEDs) performed by industry representatives.
Methods: A total of 403 consecutive patients (35% females; median age, 67 years; age range 18–97 years) with either pacemakers (n=246), implantable cardioverter-defibrillators (ICDs), (n=117) or cardiac resynchronization therapy with defibrillator (CRT-D) (n=40) applied to our hospital’s outpatient pacemaker clinic for follow-up. These patients had been followed up by industry representatives alone until September 2013 and then by a cardiologist who is dealing with cardiac electrophysiology and has a knowledge of CIED follow-up.
Results: It was ascertained that 117 (47.6%) of 246 patients with pacemakers had a programming error. Forty-three (36.8%) of 117 patients were symptomatic, and after reprogramming, all symptoms diminished partially or completely during the follow-up. Moreover, 30 (25.6%) of 117 patients with ICDs had a programming error. Furthermore, 6 (15%) of 40 patients with CRT-Ds had a programming error. To conclude, when all patients with CIEDs were assessed together, it was ascertained that 153 (38%) of 403 patients had programming errors.
Conclusion: The prevalence of inappropriate programming of CIEDs by industry representatives was quite higher than expected. Therefore, our study strongly demonstrates that CIED follow-up should not be allowed to be performed entirely by manufacturers’ representatives alone.

Keywords: cardiac resynchronisation therapy, follow-up, implantable cardioverter-defibrillator, optimization, pacemakers, programming errors


Çağın Mustafa Üreyen, Cem Yunus Baş, İsa Öner Yüksel, Görkem Kuş, Göksel Çağırcı, Şakir Arslan. Should physicians instead of industry representatives be the main actor of cardiac implantable electronic device follow-up? (Super Follow-up). Anatol J Cardiol. 2017; 18(1): 23-30

Corresponding Author: Çağın Mustafa Üreyen, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2016 Turkish Society of Cardiology